The Centers for Disease Control and Prevention (CDC) recommends that pregnant women receive an RSV vaccine during their third ...

“Appropriate people at higher risk should be vaccinated, and this will not only benefit the vaccinated person, but will ...

A new antibody shot that protects babies against RSV infection could be struggling to gain traction, Philadelphia researchers ...

New research from the Children’s Hospital of Philadelphia shows the challenges of getting families to accept a promising new drug that protects against RSV, a common cold-like virus that can cause ...

British drugmaker GSK said on Monday it had submitted an application to the U.S. Food and Drug Administration to extend the ...

The Food and Drug Administration has approved three vaccines for RSV — GSK's GSK.L Arexvy, Moderna's MRNA.O mRESVIA and Pfizer's PFE.N Abrysvo.

The eight new ACIP members met for the first time June 25 after Kennedy fired all 17 original members of the committee June 9 ...

The FDA has accepted for review the sBLA to expand the indication of Arexvy (RSV vaccine, adjuvanted) to adults aged 18 to 49 years who are at increased risk.

The US FDA approved an RSV vaccine called Arexvy. How effective is it, when will it be available, and who can take it? CNN Medical Analyst Dr. Leana Wen explains.

Child mortality has been halved in the last 25 years. Building on this progress, new innovations in immunization are working ...

RSV vaccines will be most effective at saving lives if given before infections climb, which happened unusually early last year. "Lives, hospitalizations, we could have a significant impact this year.

The US FDA approved an RSV vaccine called Arexvy. How effective is it, when will it be available, and who can take it? CNN Medical Analyst Dr. Leana Wen explains.